JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB256920

Human FOXA1 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

FOXA1 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2 and 4 bp insertion in exon2.
4 Images
Western blot - Human FOXA1 knockout HeLa cell lysate (AB256920)
  • WB

Lab

Western blot - Human FOXA1 knockout HeLa cell lysate (AB256920)

Lane 1 : Wild-type HeLa cell lysate (20μg)
Lane 2 : FOXA1 knockout HeLa cell lysate (20μg)
Lanes 1- 2 : Merged signal (red and green). Green - ab55178 observed at 49 kDa. Red - loading control ab181602 observed at 37 kDa.
ab55178 Anti-FOXA1 antibody was shown to specifically react with FOXA1 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab261823 (knockout cell lysate ab256920) was used. Wild-type and FOXA1 knockout samples were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab55178 and Anti-GAPDH antibody[EPR16891] - Loading Control (ab181602) were incubated overnight at 4°C at 1 in 500 and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) and Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
HeLa cells are predicted to express FOXA1, with no expression of FOXA2 or FOXA3.

All lanes:

Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (<a href='/en-us/products/primary-antibodies/foxa1-antibody-1b1-ab55178'>ab55178</a>) at 1/500 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

FOXA1 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human FOXA1 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-foxa1-knockout-hela-cell-line-ab261823'>ab261823</a>)

Predicted band size: 49 kDa

Observed band size: 49 kDa

false

Western blot - Human FOXA1 knockout HeLa cell lysate (AB256920)
  • WB

Lab

Western blot - Human FOXA1 knockout HeLa cell lysate (AB256920)

Lane 1 : Wild-type HeLa cell lysate (20μg)
Lane 2 : FOXA1 knockout HeLa cell lysate (20μg)
Lanes 1- 2 : Merged signal (red and green). Green - ab170933 observed at 52 kDa. Red - loading control ab8245 observed at 37 kDa.
ab170933 Anti-FOXA1 antibody [EPR10881] was shown to specifically react with FOXA1 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab261823 (knockout cell lysate ab256920) was used. Wild-type and FOXA1 knockout samples were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab170933 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

Hela cells are predicted to express FOXA1, not FOXA2 and FOXA3

All lanes:

Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [EPR10881] (<a href='/en-us/products/primary-antibodies/foxa1-antibody-epr10881-ab170933'>ab170933</a>) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

FOXA1 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human FOXA1 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-foxa1-knockout-hela-cell-line-ab261823'>ab261823</a>)

Predicted band size: 49 kDa

Observed band size: 52 kDa

false

Sanger Sequencing - Human FOXA1 knockout HeLa cell lysate (AB256920)
  • Sanger seq

Unknown

Sanger Sequencing - Human FOXA1 knockout HeLa cell lysate (AB256920)

Allele-2 : 4 bp insertion in exon2

Sanger Sequencing - Human FOXA1 knockout HeLa cell lysate (AB256920)
  • Sanger seq

Unknown

Sanger Sequencing - Human FOXA1 knockout HeLa cell lysate (AB256920)

Allele-1 : 1 bp insertion in exon2

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2 and 4 bp insertion in exon2.

Disease

Adenocarcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab256920-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human FOXA1 knockout HeLa cell lysate", "number":"AB256920-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB256920-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
FOXA1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

FOXA1 also known as Forkhead Box A1 is a transcription factor with a molecular weight of about 49 kDa. It plays a role by binding to specific DNA sequences influencing the expression of genes involved in various cellular processes. This protein is expressed in tissues like liver lungs and prostate. Researchers also refer to FOXA1 as HNF-3α emphasizing its importance in transcription regulation.
Biological function summary

FOXA1 influences the transcriptional control of genes essential for organ development and metabolic regulation. It acts as a pioneer factor opening chromatin structure to enable access for other transcription factors. FOXA1 integrates into complexes that involve histone modification affecting the chromatin state and transcription of target genes. This function is necessary for the proper differentiation and function of several tissues.

Pathways

FOXA1 participates significantly in the androgen receptor signaling pathway and the estrogen receptor signaling pathway. It interacts closely with androgen receptor facilitating the expression of genes that influence cell growth and proliferation. The involvement of FOXA1 in these pathways highlights its critical role in pathways that regulate hormone-responsive cancers and metabolic processes.

FOXA1 shows a strong association with cancers such as prostate cancer and breast cancer. FOXA1's interaction with the androgen receptor links it to prostate cancer progression while its involvement with the estrogen receptor correlates with breast cancer development. Aberrations in its expression or function can disrupt these pathways emphasizing the importance of FOXA1 in cancer biology and its potential as a therapeutic target.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com